Role of Chronic Conditions in Out-of-Pocket Costs for Preventive Care in the US
JAMA Network Open · 2026
DOI: 10.1001/jamanetworkopen.2025.53157 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2026. Verfasst von Allan Tran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Cost Sharing, Health Expenditures, Preventive Health Services. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance The Patient Protection and Affordable Care Act (ACA) requires private health insurers to cover recommended preventive services with no patient cost-sharing, but patients covered by these provisions still incur out-of-pocket (OOP) costs for which they should be exempt. To date, no work has assessed how gaps in enforcing the ACA’s cost-sharing exemption affect patients with chronic conditions, who have higher OOP costs overall, which increases the financial burden from their health care.
Objective
To determine the relative incidence, magnitude, and determinants of cost-sharing for preventive care among individuals with chronic conditions compared with individuals without such conditions. Design, Setting, and Participants This cohort study used propensity score matching of patients insured through their employers or the ACA Marketplaces, using claims and remittance data from Symphony Health Solutions’ Integrated DataVerse from 2017 to 2020. Analysis was completed between November 2024 and November 2025. Exposure Presence of ambulatory care–sensitive conditions (ACSCs) compared with no chronic conditions. Main Outcomes and Measures Primary outcomes included the incidence and amount of costs levied for preventive care. Secondary outcomes included the incidence of cost-sharing for preventive care specifically due to service code misclassification and visit complexity.
Results
A total of 1 262 414 patients (800 693 female patients [63.42%]; mean [SD] age at the time of visit, 54.46 [12.40] years) received 5 236 253 preventive services over 1 984 354 unique visits. The likelihood of a preventive service resulting in cost-sharing was significantly greater among patients with ACSCs compared with those without ACSCs (17.91% [95% CI, 17.69%-17.95%] vs 15.64% [95% CI, 15.69%-15.95%]; P < .001). Propensity score–matched models found that individuals with ACSCs had a 19.20% increase (95% CI, 18.87%-19.18%; P < .001) in the probability of facing OOP costs for preventive care, and a 20.69% (95% CI, 19.19%-20.91%; P < .001) increase in expected preventive OOP costs overall. Conclusion and Relevance These findings suggest that patients with chronic conditions were more likely to experience cost-sharing for preventive care and had greater expected spending overall. Standardizing insurer practices regarding cost-sharing exemptions can improve equitable access to high-value preventive care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
- Canadian Centre for Health Economics, University of Toronto, Toronto, Ontario, Canada.
Zitieren
APA
Tran, A., Laporte, A., Nauenberg, E., & Hoagland, A. (2026). Role of Chronic Conditions in Out-of-Pocket Costs for Preventive Care in the US. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.53157
Vancouver
Tran A, Laporte A, Nauenberg E, Hoagland A. Role of Chronic Conditions in Out-of-Pocket Costs for Preventive Care in the US. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2025.53157
BibTeX
@article{Tran2026,
author = {Tran, Allan and Laporte, Audrey and Nauenberg, Eric and Hoagland, Alex},
title = {Role of Chronic Conditions in Out-of-Pocket Costs for Preventive Care in the US},
journal = {JAMA Network Open},
year = {2026},
doi = {10.1001/jamanetworkopen.2025.53157}
}
EUVIMED